Etrovis SP Tablet is a combination medication containing Etoricoxib 60mg and Serratiopeptidase 10mg, designed to provide effective relief from pain and inflammation. Etoricoxib is a selective COX-2 inhibitor that works by reducing the production of prostaglandins, substances responsible for causing pain and inflammation in the body, making it particularly useful in managing conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain. Serratiopeptidase is a proteolytic enzyme that helps break down inflammatory by-products and promotes faster healing by reducing swelling and improving tissue repair. Together, these components offer a synergistic effect, providing both symptomatic relief and enhanced recovery in inflammatory conditions. Etrovis SP is commonly prescribed for post-operative pain, soft tissue injuries, and chronic inflammatory disorders, ensuring reduced discomfort and improved mobility. It is generally well-tolerated but should be used under medical supervision, especially in patients with a history of cardiovascular issues, gastrointestinal problems, or kidney impairment. Patients are advised to follow the prescribed dosage and avoid concurrent use with other NSAIDs to minimize potential side effects. Overall, Etrovis SP Tablet is an effective option for managing pain and inflammation with the added benefit of enzymatic support for tissue healing.